Immuron (IMRN) Gross Margin (2016 - 2024)
Immuron (IMRN) recorded quarterly Gross Margin of 66.52% in Q4 2024, down 0.85% quarter-over-quarter from 67.09% in Q4 2023, and down 57.0% on a YoY basis from 154.7% in Q1 2024.
Immuron (IMRN) Gross Margin (2016 - 2024) Analysis & Trends
Immuron's Gross Margin history runs 9 years deep, the most recent figure standing at 66.52% for Q4 2024.
- In Q4 2024, Gross Margin fell 57.0% year-over-year to 66.52%; the TTM figure through Dec 2024 stood at 66.52% (down 220.0% YoY), while the FY2025 annual figure was 65.39%, down 267.0% from the prior year.
- Gross Margin was 66.52% for Q4 2024 at Immuron, down from 67.09% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 38529715.89% in Q4 2020 to a low of 66.52% in Q4 2024.
- Historically, Gross Margin has averaged 6421679.25% across 5 years, with a median of 71.63% in 2021.
- The sharpest annual moves came in 2020 and 2021: Gross Margin surged 2000000000 bps in 2020, then tumbled 2000000000 bps in 2021.
- A 5-year view of Gross Margin shows it stood at 38529715.89% in 2020, then sank by 100 bps to 69.94% in 2021, then gained by 5 bps to 73.32% in 2022, then slipped by 8 bps to 67.09% in 2023, then fell by 1 bps to 66.52% in 2024.
- The last three Gross Margin figures came in at 66.52% (Q4 2024), 67.09% (Q4 2023), and 82.75% (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 66.52% |
| Dec 31, 2023 | 67.09% |
| Jun 30, 2023 | 82.75% |
| Dec 31, 2022 | 73.32% |
| Dec 31, 2021 | 69.94% |
| Dec 31, 2020 | 38,529,715.89% |
| Dec 31, 2019 | 72.04% |
| Dec 31, 2018 | 76.34% |
| Dec 31, 2017 | 78.75% |
| Dec 31, 2016 | 68.23% |
| Jun 30, 2016 | 73.91% |